Global and United States Gynecological Progestin Drugs Market Report & Forecast 2022-2028
1 Study Coverage
- 1.1 Gynecological Progestin Drugs Product Introduction
- 1.2 Global Gynecological Progestin Drugs Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Gynecological Progestin Drugs Sales in US$ Million for the Year 2017-2028
2 Market by Type
- 2.1 Gynecological Progestin Drugs Market Segment by Type
- 2.1.1 Progesterone
3 Market by Application
- 3.1 Gynecological Progestin Drugs Market Segment by Application
- 3.1.1 Hospital Pharmacies
4 Global Gynecological Progestin Drugs Competitor Landscape by Company
- 4.1 Global Gynecological Progestin Drugs Market Size by Company
- 4.1.1 Top Global Gynecological Progestin Drugs Manufacturers Ranked by Revenue (2021)
5 Global Gynecological Progestin Drugs Market Size by Region
- 5.1 Global Gynecological Progestin Drugs Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Gynecological Progestin Drugs Market Size in Volume by Region (2017-2028)
- 5.2.1 Global Gynecological Progestin Drugs Sales in Volume by Region: 2017-2022
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Gynecological Progestin Drugs Market Size YoY Growth 2017-2028
7 Company Profiles
- 7.1 Merck
- 7.1.1 Merck Corporation Information
8 Industry Chain and Sales Channels Analysis
- 8.1 Gynecological Progestin Drugs Industry Chain Analysis
- 8.2 Gynecological Progestin Drugs Key Raw Materials
- 8.2.1 Key Raw Materials
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
A progestogen, also referred to as a progestagen, gestagen, or gestogen, is a type of medication which produces effects similar to those of the natural female sex hormone progesterone in the body. A progestin is a synthetic progestogen. Progestogens are used most commonly in hormonal birth control and menopausal hormone therapy.
They can also be used in the treatment of gynecological conditions, to support fertility and pregnancy, to lower sex hormone levels for various purposes, and for other indications.
Market Analysis and Insights: Global and United States Gynecological Progestin Drugs Market
This report focuses on global and United States Gynecological Progestin Drugs market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Gynecological Progestin Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Progesterone accounting for % of the Gynecological Progestin Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital Pharmacies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Gynecological Progestin Drugs market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Gynecological Progestin Drugs Scope and Market Size
Gynecological Progestin Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Gynecological Progestin Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Gynecological Progestin Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Gynecological Progestin Drugs market is segmented into
Progesterone
Dydrogesterone
Others
Segment by Application, the Gynecological Progestin Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Gynecological Progestin Drugs Market Share Analysis
Gynecological Progestin Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Gynecological Progestin Drugs business, the date to enter into the Gynecological Progestin Drugs market, Gynecological Progestin Drugs product introduction, recent developments, etc.
The major vendors covered:
Merck
Teva Generics
Besins Healthcare
Virtus Pharmaceuticals, LLC
BionPharma
Aquatic Remedies
Zhejiang Xianju Pharmaceutical
Zhejiang Aisheng Pharmaceutical
Zhejiang Medicine
Hubei Dongxin Pharmaceutical
Tianjin Jinyao Pharmaceutical
Guangzhou Baiyunshan Mingxing Pharmaceutical